These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21304506)

  • 1. Pharmacogenetics: Anti-TNF therapy in RA--towards personalized medicine?
    Verweij CL
    Nat Rev Rheumatol; 2011 Mar; 7(3):136-8. PubMed ID: 21304506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci.
    Plant D; Bowes J; Potter C; Hyrich KL; Morgan AW; Wilson AG; Isaacs JD; ; ; Barton A
    Arthritis Rheum; 2011 Mar; 63(3):645-53. PubMed ID: 21061259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis.
    Bek S; Bojesen AB; Nielsen JV; Sode J; Bank S; Vogel U; Andersen V
    Pharmacogenomics J; 2017 Oct; 17(5):403-411. PubMed ID: 28607508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics of tumor necrosis factor antagonists in rheumatoid arthritis.
    Ranganathan P
    Pharmacogenomics; 2005 Jul; 6(5):481-90. PubMed ID: 16013998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of polymorphisms in TRAILR1 and TNFR1A on the response to anti-TNF therapies in patients with rheumatoid and psoriatic arthritis.
    Morales-Lara MJ; Cañete JD; Torres-Moreno D; Hernández MV; Pedrero F; Celis R; García-Simón MS; Conesa-Zamora P
    Joint Bone Spine; 2012 Dec; 79(6):591-6. PubMed ID: 22480748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting response to TNF antagonists in rheumatoid arthritis: the promise of pharmacogenetics research using clinical registries.
    Greenberg JD; Ostrer H
    Bull NYU Hosp Jt Dis; 2007; 65(2):139-42. PubMed ID: 17581108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis.
    Coenen MJ; Toonen EJ; Scheffer H; Radstake TR; Barrera P; Franke B
    Pharmacogenomics; 2007 Jul; 8(7):761-73. PubMed ID: 17638513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics of Anti-TNF Treatment Response Marks a New Era of Tailored Rheumatoid Arthritis Therapy.
    Wysocki T; Paradowska-Gorycka A
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF-alpha-308 G/A polymorphism and responsiveness to TNF-alpha blockade therapy in moderate to severe rheumatoid arthritis: a systematic review and meta-analysis.
    O'Rielly DD; Roslin NM; Beyene J; Pope A; Rahman P
    Pharmacogenomics J; 2009 Jun; 9(3):161-7. PubMed ID: 19365401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on pharmacogenomics in rheumatoid arthritis with a focus on TNF-blocking agents.
    Ranganathan P
    Curr Opin Mol Ther; 2008 Dec; 10(6):562-7. PubMed ID: 19051134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Combined Transcriptomic and Genomic Analysis Identifies a Gene Signature Associated With the Response to Anti-TNF Therapy in Rheumatoid Arthritis.
    Aterido A; Cañete JD; Tornero J; Blanco F; Fernández-Gutierrez B; Pérez C; Alperi-López M; Olivè A; Corominas H; Martínez-Taboada V; González I; Fernández-Nebro A; Erra A; López-Lasanta M; López Corbeto M; Palau N; Marsal S; Julià A
    Front Immunol; 2019; 10():1459. PubMed ID: 31312201
    [No Abstract]   [Full Text] [Related]  

  • 12. Associations between PTPRC rs10919563 A/G and FCGR2A R131H polymorphisms and responsiveness to TNF blockers in rheumatoid arthritis: a meta-analysis.
    Lee YH; Bae SC
    Rheumatol Int; 2016 Jun; 36(6):837-44. PubMed ID: 27074847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in rheumatoid arthritis.
    Liu C; Batliwalla F; Li W; Lee A; Roubenoff R; Beckman E; Khalili H; Damle A; Kern M; Furie R; Dupuis J; Plenge RM; Coenen MJ; Behrens TW; Carulli JP; Gregersen PK
    Mol Med; 2008; 14(9-10):575-81. PubMed ID: 18615156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics of etanercept in rheumatoid arthritis.
    Danila MI; Hughes LB; Bridges SL
    Pharmacogenomics; 2008 Aug; 9(8):1011-5. PubMed ID: 18681777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variants that predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis: current challenges and future directions.
    Plenge RM; Criswell LA
    Curr Opin Rheumatol; 2008 Mar; 20(2):145-52. PubMed ID: 18349743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenomics of biological treatment in rheumatoid arthritis.
    Xie X; Zhang D; Chen JW; Tian J; Ling GH; Li F
    Expert Opin Biol Ther; 2014 Feb; 14(2):157-64. PubMed ID: 24295560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between tumor necrosis factor-α (TNF-α) promoter -308 G/A and response to TNF-α blockers in rheumatoid arthritis: a meta-analysis.
    Zeng Z; Duan Z; Zhang T; Wang S; Li G; Gao J; Ye D; Xu S; Xu J; Zhang L; Pan F
    Mod Rheumatol; 2013 May; 23(3):489-95. PubMed ID: 22760475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF antagonists opened the way to personalized medicine in rheumatoid arthritis.
    Breedveld F
    Mol Med; 2014 Dec; 20 Suppl 1(Suppl 1):S7-9. PubMed ID: 25549234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of pharmacogenetics in anti-TNF treatment of rheumatoid arthritis and Crohn's disease.
    Kooloos WM; de Jong DJ; Huizinga TW; Guchelaar HJ
    Drug Discov Today; 2007 Feb; 12(3-4):125-31. PubMed ID: 17275732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the FcGRIIIa polymorphism in modifying the association between treatment and outcome in patients with rheumatoid arthritis treated with rituximab versus TNF-α antagonist therapies.
    Sarsour K; Greenberg J; Johnston JA; Nelson DR; O'Brien LA; Oddoux C; Ostrer H; Pearlman A; Reed G
    Clin Exp Rheumatol; 2013; 31(2):189-94. PubMed ID: 23294992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.